
European Journal of Medicinal Chemistry p. 899 - 907 (1992)
Update date:2022-08-03
Topics:
Le Roux
Auger
Va Heijenoort
Blanot
In order to obtain inhibitors of the meso-diaminopimelate-adding enzyme, which catalyzes an early reaction in the biosynthesis of bacterial peptidoglycan, several new peptide derivatives of general formula, N(α)-propionyl-L-alanyl-D (or ambo)-Xaa were synthesized: four transition-state analogs (Xaa = phosphinothricin, homocysteic acid, buthionine sulfoximine, buthionine sulfoximine phosphate), three analogs of γ-D-glytamyl phosphate (Xaa = 3-phosphonoacetamideo-alanine, 3-phosphonomethylamino-aspartic acid, 2-amino-6-phosphonohexanoic acid), and one derivative with Xaa = ornithine. After preincubation with partially purified meso-diaminopimelate-adding enzyme from Escherichia coli, peptide derivatives with Xaa - buthionine sulfoximine, 3-phosphonoacetamido-alanine and 2-amino-6-phosphonohexanoic acid appeard to be among the best inhibitors obtained up to date, with I50 values between 0.6 and 1.2 mM. When the two first compounds were tested for in vitro antibacterial activity, they gave negative results.
View MoreShanghai HengXun Pharmaceutical Tech. Co., Ltd.
Contact:86-86-52730756
Address:Room 603, No. 240, Tianmuzhong Road, Zhabei, Shanghai, China
Frapp's Chemical (NFTZ) Co.,Ltd
Contact:+86-576-86137892
Address:General Chamber of Commercial Building, 159 Wanchang Middle Road, Wenling, Zhejiang, China
Zhenjiang Haitong Chemical Industry Co., Ltd.
Contact:+86 (511) 8448-0369
Address:Baoyan Town, Dantu District, Zhenjiang City, Jiangsu, China
Contact:86-310-8067016
Address:East Fuhua Road,Tiexi Chemical Industrial Estate,Hebei,China
HUNAN CHEMAPI BIOLOGICAL TECHNOLOGY CO.,LTD.
Contact:+86-186-02659358
Address:1004, building 3, Wanke Jinsemaitianyuan, 498 Guitang Road, Yuhua District, Changsha City, Hunan Province, China
Doi:10.1016/0040-4020(65)80039-4
(1965)Doi:10.1039/P29950000443
(1995)Doi:10.1002/hlca.19930760221
(1993)Doi:10.1021/om400965j
(2013)Doi:10.1016/j.ejmech.2013.09.005
(2013)Doi:10.1021/acsmedchemlett.8b00551
(2019)